(Q34471515)

2 August 2017

1 reference

title

Update on augmentation of antidepressant response in resistant depression (English)

1 reference

2 August 2017

2

Anna Lembke

1 reference

2 August 2017

Charles DeBattista

1

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 December 2005

1 reference

Current Psychiatry Reports

2 August 2017

published in

1 reference

2 August 2017

volume

7

1 reference

2 August 2017

issue

6

1 reference

2 August 2017

page(s)

435-440

1 reference

Therapeutic alternatives for difficult-to-treat depression: a narrative review of the state of the evidence

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11920-005-0064-X

Trazodone for antidepressant-associated insomnia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-005-0064-X

Aripiprazole augmentation in treatment-resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-005-0064-X

Signal transduction pathways. Molecular targets for lithium's actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-005-0064-X

Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression

21 January 2018

1 reference

12 December 2020

Pindolol augmentation of selective serotonin reuptake inhibitors: PET evidence that the dose used in clinical trials is too low.

1 reference

12 December 2020

Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized study

1 reference

12 December 2020

New approaches to managing psychotic depression

1 reference

12 December 2020

Aripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and anxiety disorder patients

1 reference

12 December 2020

Lithium augmentation in depressive patients not responding to selective serotonin reuptake inhibitors

1 reference

12 December 2020

Partial response, nonresponse, and relapse with selective serotonin reuptake inhibitors in major depression: a survey of current "next-step" practices.

1 reference

12 December 2020

A comparison of triiodothyronine and thyroxine in the potentiation of tricyclic antidepressants

1 reference

12 December 2020

Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled study.

1 reference

12 December 2020

Dexamethasone augmentation in treatment-resistant depression

1 reference

12 December 2020

Treatment choice after one antidepressant fails: a survey of northeastern psychiatrists

1 reference

12 December 2020

Possible trazodone potentiation of fluoxetine: a case series

1 reference

12 December 2020

Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial

1 reference

12 December 2020

Combining stimulants with monoamine oxidase inhibitors: a review of uses and one possible additional indication

1 reference

12 December 2020

An open label trial of C-1073 (mifepristone) for psychotic major depression

1 reference

12 December 2020

Novel uses of thyroid hormones in patients with affective disorders

1 reference

12 December 2020

Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder

1 reference

12 December 2020

Dexamethasone for the treatment of depression: a randomized, placebo-controlled, double-blind trial

1 reference

12 December 2020

An 8-week open-label trial of a 6-day course of mifepristone for the treatment of psychotic depression

1 reference

12 December 2020

A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness.

1 reference

12 December 2020

Lithium Augmentation of Nortriptyline for Subjects Resistant to Multiple Antidepressants

1 reference

12 December 2020

Augmentation of standard antidepressants with atypical antipsychotic agents for treatment-resistant major depressive disorder.

1 reference

12 December 2020

Estrogen replacement therapy in the treatment of major depressive disorder in perimenopausal women.

1 reference

12 December 2020

Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature

1 reference

12 December 2020

Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy.

1 reference

12 December 2020

Pindolol augmentation of selective serotonin reuptake inhibitors: accounting for the variability of results of placebo-controlled double-blind studies in patients with major depression.

1 reference

12 December 2020

Thyroid hormone treatment of primary unipolar depression: a review.

1 reference

12 December 2020

Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors

1 reference

12 December 2020

Lithium augmentation therapy in refractory depression: clinical evidence and neurobiological mechanisms

1 reference

12 December 2020

Use of bupropion with SRIs and venlafaxine

1 reference

12 December 2020

The Hamilton Depression Rating Scale: has the gold standard become a lead weight?

1 reference

12 December 2020

Acute antidepressant effects of intravenous hydrocortisone and CRH in depressed patients: a double-blind, placebo-controlled study

1 reference

12 December 2020

Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial

1 reference

12 December 2020

Rapid reversal of psychotic depression using mifepristone

1 reference

12 December 2020

Pindolol Induces a Rapid Improvement of Depressed Patients Treated With Serotonin Reuptake Inhibitors

1 reference

12 December 2020

Double-blind study of high-dose fluoxetine versus lithium or desipramine augmentation of fluoxetine in partial responders and nonresponders to fluoxetine.

1 reference

12 December 2020

Psychostimulant augmentation of second generation antidepressants: a case series

1 reference

12 December 2020

A prospective trial of modafinil as an adjunctive treatment of major depression

1 reference

12 December 2020

Failure of T3 to potentiate tricyclic antidepressant response

1 reference

12 December 2020

An open study of triiodothyronine augmentation of selective serotonin reuptake inhibitors in treatment-resistant major depressive disorder.

1 reference

12 December 2020

Safety and efficacy of testosterone gel 1% augmentation in depressed men with partial response to antidepressant therapy

1 reference

12 December 2020

Stimulants in the treatment of depression: a critical overview

1 reference

12 December 2020

Positive treatment effect of estradiol in postpartum psychosis: a pilot study

1 reference

12 December 2020

The pharmacology of putative early-onset antidepressant strategies

1 reference

12 December 2020

A novel augmentation strategy for treating resistant major depression

1 reference

12 December 2020

Consensus development conference on antipsychotic drugs and obesity and diabetes

1 reference

12 December 2020

Study designs and outcomes in antidepressant clinical trials.

1 reference

12 December 2020

A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine

1 reference

12 December 2020

Neuropsychological deficits in psychotic versus nonpsychotic major depression and no mental illness.

1 reference

12 December 2020

10.1007/S11920-005-0064-X

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

1045625840

0 references

1 reference